Medtronic (NYSE:MDT) and Hansen Medical (NSDQ:HNSN) said they are slated to present new clinical information at this year’s annual VEITHSymposium in New York City. Medtronic said today it plans to present 4-year subset data results from the ENGAGE global registry study of its Endurant AAA stent graft system. The trial analyzed patients with hostile neck anatomies treated with […]
Clinical Trials
AUM Cardiovascular finishes pivotal trial enrollment
AUM Cardiovascular said last week it completed enrollment for the pivotal study of its CADence handheld heart disease diagnostics device. Aum’s Cadence is designed to identify obstructions in the coronary arteries by detecting acoustic signals generated by the turbulence created as blood flows past the obstruction, according to the company’s site. The company’s name is based on a […]
FDA grants expedited access for UW’s wearable artificial kidney
The FDA granted expedited access pathway status for a Wearable Artificial Kidney being developed at the University of Washington’s Medical Center in Seattle, the school reported earlier this month. The Wearable Artificial Kidney is a battery-powered hemodialysis machine composed of miniaturized components worn as a tool belt and connected to the patient via catheter, UW Medical said. The […]
U.K.’s NHS uses McLaren Formula 1 tech for pediatric monitoring
The U.K.’s National Health Service is using technology originally developed for McLaren’s Formula One team for its drivers to monitor pediatric patients, according to The Telegraph. The technology, which continuously monitors heart rate, breathing rate and oxygen levels, is being tested at the Birmingham Children’s Hospital as part of the real-time adaptive and predictive indicator […]
LoneStar Heart touts 1-year Algisyl data
LoneStar Heart yesterday presented 1-year data from a follow-up study of its Algisyl hydrogel cardiac implant designed to treat patients with failing heart muscle. The presentation was made at the American Heart Association’s annual meeting in Orlando and published in the European Journal of Heart Failure. Algisyl is a novel inert hydrogel that is designed to be […]
Derma Sciences scraps trial, mulls sale
Derma Sciences (NSDQ:DSCI) said today it would evaluate all options, including a sale, after scrapping a trial of its aclerastide drug for diabetic foot ulcers. DSCI shares plunged as much as 31%, dropping under their 6-year low today. The company makes wound care and regenerative medicine products. Aclerastide was its only drug candidate. Princeton, N.J.-based Derma Sciences said […]
Boston Scientific touts Watchman study data
Boston Scientific (NYSE:BSX) yesterday presented data on its Watchman left atrial appendage occlusion device. The data was presented at the annual American Heart Association’s Scientific Sessions in Orlando, Fla. The data comes from the Ewolution registry, the 1st real-world study of the Marlborough, Mass.-based company’s Watchman device. The patient population of the study was the ‘highest […]
C2 Therapeutics touts ColdPlay ablation system study data
C2 Therapeutics today released data from a study of its ColdPlay cryoballoon focal ablation system reporting no adverse events or complications with the device. The Redwood City, Calif.-based company’s device is designed to treat precursors to esophageal cancer known as Barrett’s esophagus. The Coldplay device uses extreme cold to destroy targeted diseased tissue while minimizing […]
Xeltis completes 2nd feasibility trial of cardiac valve system
Xeltis said today it completed its 2nd feasibility trial of its bioabsorbable regenerative heart valve technology designed to allow endogenous tissue restoration. The Swiss med tech firm is designing valves and vessels out of polymers structured as a “porous matrix” designed to be absorbed and leave the patient with its own healthy tissue, the company […]
InnFocus wins FDA clearance for glaucoma trial expansion
InnFocus said today it won FDA approval to expand a clinical study of its Microshunt glaucoma drainage system to cover trabeculectomy. The Microshunt system is designed to help reduce pressure within the eye in patients with moderate and late stage open angle glaucoma, and is intended to be an alternative to traditional glaucoma surgery, the […]
Study shows advantages of mitral valve replacement over repair
(Reuters) — Patients with severe leakage from the mitral valve of the heart who had the valve replaced had significantly lower rates of recurrence and heart failure two years after the procedure than those who underwent surgical repair, according to data presented on Monday. Mitral valve regurgitation, in which blood leaks backward through the valve […]